Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
China flag China · Delayed Price · Currency is CNY
162.73
-2.97 (-1.79%)
Sep 11, 2026, 3:04 PM CST

SHE:300760 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
34,10333,17236,62434,87530,35425,258
Other Revenue
183.59110.11101.6856.6111.8311.73
34,28633,28236,72634,93230,36625,270
Revenue Growth
4.09%-9.38%5.13%15.04%20.17%20.18%
Cost of Revenue
14,03513,52713,76712,76810,9568,967
Gross Profit
20,25119,75522,95922,16419,41016,303
Selling, General & Admin
6,8026,6966,8836,5346,1225,105
Research & Development
3,5423,5793,6663,4332,9232,524
Other Operating Expenses
126.84-13.4-261.66-308.79-80.36-83.14
Operating Expenses
10,55010,45610,5869,9039,0017,539
Operating Income
9,7019,29912,37312,26110,4098,764
Interest Expense
-25.72-24.02-19.41-13-10.69-8.63
Interest & Investment Income
523.85594.86626.87821.64357.91408.14
Currency Exchange Gain (Loss)
-851.85-113.43-51.28119.17171.96-227.66
Other Non Operating Income (Expenses)
-70.29-80.27-87.45-72.51-67.82-85.92
EBT Excluding Unusual Items
9,2779,67612,84213,11710,8608,850
Gain (Loss) on Sale of Investments
0.820.49109.3369.56-26.449.88
Gain (Loss) on Sale of Assets
0.9610.724.242.466.164.07
Asset Writedown
-0.48-16.47-1.75-274.92-0.74-7.47
Legal Settlements
-20.4-21.38-14.25-12.65-3.3-5.7
Other Unusual Items
55.6724.9480.25109.68117.5166.78
Pretax Income
9,3139,67413,02013,01110,9549,017
Income Tax Expense
1,0471,2221,2801,4331,3431,013
Earnings From Continuing Operations
8,2668,45111,74011,5789,6118,004
Minority Interest in Earnings
-401.89-315.7-71.483.81-3.54-2.49
Net Income
7,8648,13611,66811,5829,6078,002
Net Income to Common
7,8648,13611,66811,5829,6078,002
Net Income Growth
-14.31%-30.28%0.74%20.56%20.07%20.18%
Shares Outstanding (Basic)
1,2121,2121,2111,2121,2101,215
Shares Outstanding (Diluted)
1,2121,2121,2111,2121,2101,215
Shares Change
0.04%0.03%-0.04%0.11%-0.36%-0.07%
EPS (Basic)
6.496.719.649.567.946.59
EPS (Diluted)
6.496.719.639.567.946.59
EPS Growth
-14.34%-30.30%0.79%20.42%20.50%20.28%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
9,0158,10710,4738,37310,2267,596
Free Cash Flow Per Share
7.446.698.656.918.456.25
Dividend Per Share
2.9904.3806.2705.8004.5003.500
Dividend Growth
-39.35%-30.14%8.10%28.89%28.57%40.00%
Gross Margin
59.06%59.36%62.51%63.45%63.92%64.52%
Operating Margin
28.29%27.94%33.69%35.10%34.28%34.68%
Profit Margin
22.94%24.45%31.77%33.16%31.64%31.66%
Free Cash Flow Margin
26.29%24.36%28.52%23.97%33.67%30.06%
EBITDA
11,32810,85213,71213,15811,1889,380
EBITDA Margin
33.04%32.61%37.34%37.67%36.84%37.12%
D&A For EBITDA
1,6271,5531,339896.04779.11616.47
EBIT
9,7019,29912,37312,26110,4098,764
EBIT Margin
28.29%27.94%33.69%35.10%34.28%34.68%
Effective Tax Rate
11.25%12.64%9.83%11.01%12.26%11.24%
Revenue as Reported
33,28233,28236,72634,93230,36625,270
Advertising Expenses
-303.72332.39359.41288.69223.68